Dr. Erica Pascal is a partner in DLA Piper’s Patent Litigation practice
Are IPRs Impacting the Pharmaceutical Industry?
As more patents make their way through IPRs, the balance of how the pharmaceutical industry selects between IPRs and district court litigation will likely evolve.